ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 100 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $784,000 | +114.8% | 45,497 | +81.0% | 0.00% | – |
| Q4 2021 | $365,000 | +2.5% | 25,133 | +27.1% | 0.00% | – |
| Q3 2021 | $356,000 | -83.2% | 19,773 | -76.5% | 0.00% | -100.0% |
| Q1 2021 | $2,124,000 | +11078.9% | 84,276 | +357.6% | 0.00% | – |
| Q1 2020 | $19,000 | -92.3% | 18,418 | -85.9% | 0.00% | – |
| Q4 2019 | $247,000 | +814.8% | 130,565 | +417.8% | 0.00% | – |
| Q3 2019 | $27,000 | -86.4% | 25,216 | -72.2% | 0.00% | – |
| Q2 2019 | $199,000 | -42.0% | 90,867 | +58.8% | 0.00% | – |
| Q1 2019 | $343,000 | -51.9% | 57,221 | -40.7% | 0.00% | -100.0% |
| Q4 2018 | $713,000 | -52.8% | 96,422 | -7.3% | 0.00% | 0.0% |
| Q3 2018 | $1,510,000 | -32.1% | 104,026 | -6.6% | 0.00% | -50.0% |
| Q2 2018 | $2,224,000 | +181.5% | 111,365 | +146.9% | 0.00% | +100.0% |
| Q1 2018 | $790,000 | +28.0% | 45,111 | +80.2% | 0.00% | 0.0% |
| Q4 2017 | $617,000 | +4.8% | 25,034 | +9.7% | 0.00% | 0.0% |
| Q3 2017 | $589,000 | -23.1% | 22,816 | -19.2% | 0.00% | 0.0% |
| Q2 2017 | $766,000 | -53.6% | 28,243 | -49.0% | 0.00% | -66.7% |
| Q1 2017 | $1,652,000 | +83.6% | 55,397 | +67.0% | 0.00% | +200.0% |
| Q4 2016 | $900,000 | – | 33,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $35,188,000 | 48.80% |
| VR Adviser, LLC | 4,563,962 | $82,151,000 | 10.55% |
| COMMODORE CAPITAL LP | 2,190,291 | $39,425,000 | 10.39% |
| Foresite Capital Management IV, LLC | 3,399,034 | $61,183,000 | 9.01% |
| Foresite Capital Management V, LLC | 1,258,243 | $22,648,000 | 7.04% |
| Parkman Healthcare Partners LLC | 1,306,460 | $23,516,000 | 5.95% |
| Asymmetry Capital Management, L.P. | 241,701 | $4,351,000 | 2.62% |
| Jetstream Capital LLC | 140,000 | $2,520,000 | 2.44% |
| Aisling Capital Management LP | 634,455 | $11,420,000 | 2.28% |
| Samsara BioCapital, LLC | 794,171 | $14,295,000 | 2.24% |